Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non–ST elevation myocardial infarction
Emil Loldrup Fosbøl(University of Copenhagen), Eric D. Peterson(The University of Texas Southwestern Medical Center), Laine Thomas(Duke University), Roger M. Mills(Janssen (Belgium)), Matthew T. Roe(Clinical Research Institute), Karen P. Alexander(Clinical Research Institute), Renato D. Lópes(Duke University), Shuang Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Bimal R. Shah(Duke University), Winslow Klaskala(Johnson & Johnson (United States)), Tracy Y. Wang(Clinical Research Institute), Jonathan P. Piccini(Clinical Research Institute)
Cited by 48
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
|Circulation|2011|1.8k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k